Literature DB >> 25214952

Serum brain natriuretic peptide in children with Kawasaki disease.

Yu-Ping Sun1, Chao-Ping Wei1, Wen-di Wang1, Xing-Chang Zheng1, Ye-Jun Wang1, Shao-Chun Ma1, Ying-Jun Xu1.   

Abstract

BACKGROUND: Kawasaki disease (KD) is a common cause of acquired heart disease in children. Recent studies have focused on the biochemical markers of the myocardium, their high sensitivity and specificity and significance in the diagnosis of KD. This study aimed to determine the serum level of brain natriuretic peptide (BNP) and its relation with the heart function of children with KD and to explore its clinical value in diagnosis of KD.
METHODS: Forty-three KD children, aged from 5 months to 8 years (mean 2.3±0.6 years), were admitted to Qingdao Children's Hospital from February 2007 to April 2009. Among them 27 were male, and 16 female. The 43 patients served as a KD group. Patients with myocarditis, cardiomyopathy, congenital heart disease and other primary heart diseases were excluded. Thirty healthy children, aged from 3 months to 15 years (mean 2.5±0.8 years) or 17 males and 13 females served as a control group. There were no significant differences in age and gender between the two groups (P>0.05). In the KD group, ELISA was used to measure the levels of serum BNP in acute and convalescent stages; and in the control group, the levels of serum BNP were measured once randomly. Left ventricular ejection fraction (LVEF), left ventricular shorten fraction (LVSF), cardiac index (CI) and left ventricular inflow velocity through the mitral annulus (including E-velocity and A-velocity) were measured by two-dimensional echocardiography in the acute and convalescent stages in the KD group. All data were expressed as mean±SD. The methods of analysis included Student's t test and the linear regression analysis test. P<0.05 was considered statistically significant.
RESULTS: The level of serum BNP in the acute stage (517.26±213.40) ng/ml was significantly higher than that in the convalescent stage (91.56±47.97) ng/ml in the control group (37.55±7.56) ng/ml (P<0.01). The levels of LVEF, LVSF and CI in the acute stage were significantly lower than those in the convalescent stage (P<0.05), but the E/A level was not significantly different between the acute and convalescent stages (P>0.05). Linear regression analysis showed that the BNP level was negatively correlated with the levels of LVEF, LVSF and CI(r=-0.63, -0.52, -0.53, P<0.05), but not significantly correlated with the E/A level (r=-0.18, P>0.05).
CONCLUSION: The levels of serum BNP are significantly increased in KD patients, and are negatively correlated with the levels of LVEF, LVSF, and CI. The detection of serum BNP level is of clinical significance in the diagnosis of KD.

Entities:  

Keywords:  Cardiac index; Children; Correlation; E/A; Ejection fraction; Kawasaki disease; Natriuretic peptide, brain; Shorten fraction, left ventricular; left ventricular

Year:  2010        PMID: 25214952      PMCID: PMC4129751     

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  24 in total

1.  Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.

Authors:  P A Brogan; V Shah; N Klein; M J Dillon
Journal:  Arthritis Rheum       Date:  2004-02

2.  Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease.

Authors:  Andreas Koch; Tobias Kitzsteiner; Stefan Zink; Robert Cesnjevar; Helmut Singer
Journal:  Int J Cardiol       Date:  2006-06-06       Impact factor: 4.164

Review 3.  Toll-like receptors in innate immunity.

Authors:  Kiyoshi Takeda; Shizuo Akira
Journal:  Int Immunol       Date:  2005-01       Impact factor: 4.823

Review 4.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

5.  Dilated coronary arterial lesions in the late period after Kawasaki disease.

Authors:  E Tsuda; T Kamiya; Y Ono; K Kimura; S Echigo
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

6.  [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].

Authors:  Yu-rong Wu; Shu-bao Chen; Mei-rong Huang; Yu-qi Zhang; Kun Sun; Sun Chen
Journal:  Zhonghua Er Ke Za Zhi       Date:  2005-03

7.  Changes in causes of sudden deaths by decade in patients with coronary arterial lesions due to Kawasaki disease.

Authors:  Etsuko Tsuda; Yoshio Arakaki; Toshio Shimizu; Heima Sakaguchi; Shinichiro Yoshimura; Satoshi Yazaki; Shigeyuki Echigo
Journal:  Cardiol Young       Date:  2005-10       Impact factor: 1.093

8.  Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease.

Authors:  S Kurotobi; N Kawakami; K Shimizu; H Aoki; S Nasuno; K Takahashi; S Kogaki; K Ozono
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

9.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

10.  B-type natriuretic peptide in paediatric patients with congenital heart disease.

Authors:  Andreas Koch; Stefan Zink; Helmut Singer
Journal:  Eur Heart J       Date:  2006-02-08       Impact factor: 29.983

View more
  1 in total

Review 1.  Clinical Manifestations and Laboratory Findings of Kawasaki Disease: Beyond the Classic Diagnostic Features.

Authors:  Wendy Lee; Chooi San Cheah; Siti Aisyah Suhaini; Abdullah Harith Azidin; Mohammad Shukri Khoo; Noor Akmal Shareela Ismail; Adli Ali
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.